Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lean On Me: WHO Offers Practical Advice On Regulatory Reliance

Draft Proposals Cover Full Product Life Cycle

Executive Summary

A new draft document by the World Health Organization explains how regulatory authorities can leverage the work done by others to gain efficiencies and avoid duplication.

You may also be interested in...



Regulatory Reliance Behind The Success Of African COVID-19 Vaccine Approvals

Regulatory reliance and work-sharing are becoming increasingly popular as a way of avoiding duplication and speeding up drug and vaccine assessments, but while there are many benefits, regulators should also be aware of some potential pitfalls, delegates at the TOPRA annual symposium heard this week.

Global Regulators Focus On Promoting Reliance During Public Health Emergencies

Agencies participating in the International Pharmaceutical Regulators Programme discussed priorities, welcomed the UK as the newest IPRP member and endorsed a new regulatory tool to support the assessment of quality-related information in marketing applications.

Global Regulators Focus On Promoting Reliance During Public Health Emergencies

Agencies participating in the International Pharmaceutical Regulators Programme discussed priorities, welcomed the UK as the newest IPRP member and endorsed a new regulatory tool to support the assessment of quality-related information in marketing applications.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS142349

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel